Brian T. Helfand
机构:Endeavor Health, University of Chicago · ORCID:0000-0002-7707-3318
发表论文 446 篇 · 总被引 10043 次 · h-index 49
代表论文
- Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study (2026 · Nature Cancer · 被引 5)
- Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study (2026 · European Urology · 被引 3)
- Safety and efficacy of aquablation in men 80 years or older: an analysis of the international collaborative aquablation research urology society (ICARUS) real-world database (2025 · World Journal of Urology · 被引 3)
- Real-World outcomes of aquablation for benign prostatic hyperplasia: a comparative analysis of the international collaborative aquablation research urology society (ICARUS) database, WATER and WATER-II trials (2026 · World Journal of Urology · 被引 2)
- Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes (2025 · The Prostate · 被引 2)
- Germline genetic risk and prostate cancer–specific mortality in a population-based incident cohort (2026 · Prostate Cancer and Prostatic Diseases · 被引 1)